The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
221
University Hospital Ghent
Ghent, Belgium
The difference between study groups in the change of asthma control from baseline and follow-up visits
Time frame: after 1, 3 and 6 months
Peak flow
Time frame: after 3 and 6 months
Knowledge of asthma and treatment
Time frame: after 6 months
Asthma quality of life questionnaire (AQLQ)
Time frame: after 6 months
Therapy adherence
Inhalation techniques
Time frame: after 6 months
Smoking
Time frame: after 6 months
Asthma exacerbations
Time frame: after 6 months
General Practitioner (GP) visits, emergency room visits and hospitalisations
Working days lost and school days lost
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.